Clinical Trials Logo

Hypovolemia clinical trials

View clinical trials related to Hypovolemia.

Filter by:

NCT ID: NCT04283851 Completed - Surgery Clinical Trials

Dynamic Parameters in Evaluation of Fluid Responsiveness

Start date: February 1, 2020
Phase:
Study type: Observational

Intravenous infusion of fluids in patients after surgery is a very important part of treatment. However, administering too much or too little fluid can lengthen the stay in the intensive care unit or even harm the patient. Therefore, fluid therapy should be tailored to the individual needs of each patient. Several methods are available to assess which patients will likely benefit from fluid administration. However, each of these methods is useful only under certain conditions. The study aims to explore some less-known, yet promising tests which could make adequate fluid administration more precise and easier to achieve.

NCT ID: NCT04202432 Completed - Hypovolemia Clinical Trials

Clinical Validation of Algorithms for Mean Systemic Filling Pressure and Automated Cardiac Output

PP3D
Start date: June 24, 2019
Phase:
Study type: Observational

Prospective combined clinical validation of an algorithmic calculated mean systemic filling pressure (Pms-Nav) with the gold standard for Pms (Pms calculated from venous return curves during inspiratory hold procedures with incremental airway pressures; Pms-Insp). Secondary correlation between invasive cardiac output measurement versus 3D TOE and carotid echo doppler measured cardiac output.

NCT ID: NCT04139031 Completed - Hypovolemic Clinical Trials

Corrected Flow Time in the Carotid Artery as a Predictor of Fluid Responsiveness in Mechanically Ventilated Patients With Low Tidal Volume in the Intensive Care Unit

Start date: November 5, 2019
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate predictability of carotid corrected flow time for fluid responsiveness in mechanically ventilated patients with low tidal volume in the intensive care unit.

NCT ID: NCT04056065 Completed - Blood Loss Clinical Trials

PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock

Start date: May 29, 2017
Phase: Phase 2
Study type: Interventional

This is a prospective, multi-centric, randomized, double-blind, parallel, controlled phase-II efficacy clinical study of PMZ-2010 therapy in patients with hypovolemic shock. Centhaquine is highly safe and well tolerated. Toxicological studies showed high safety margin in preclinical studies. Its safety and tolerability has been demonstrated in a human phase I study in 25 subjects (CTRI/2014/06/004647; NCT02408731).

NCT ID: NCT04045327 Completed - Hypovolemic Shock Clinical Trials

Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock

Start date: January 31, 2019
Phase: Phase 3
Study type: Interventional

This is a prospective, multi-centric, randomized, double-blind, parallel, controlled phase-III efficacy clinical study of PMZ-2010 therapy in patients with hypovolemic shock. Centhaquine (previously used names, centhaquin and PMZ-2010; International Non-proprietary Name (INN) recently approved by WHO is centhaquine) has been found to be an effective resuscitative agent in rat, rabbit and swine models of hemorrhagic shock, it decreased blood lactate, increased mean arterial pressure, cardiac output, and decreased mortality. An increase in cardiac output during resuscitation is mainly attributed to an increase in stroke volume. Centhaquine acts on the venous α2B-adrenergic receptors and enhances venous return to the heart, in addition, it produces arterial dilatation by acting on central α2A-adrenergic receptors to reduce sympathetic activity and systemic vascular resistance.

NCT ID: NCT03926910 Completed - Cardiac Surgery Clinical Trials

Ventricular Stimulation as Predictor of Hypovolemia After Cardiac Surgery

TESTI
Start date: July 22, 2019
Phase: N/A
Study type: Interventional

The purpose of the study is to validate a ventricular pacing test as a predictor of preload dependency in post cardiac surgery patients.

NCT ID: NCT03915587 Completed - Hypovolemia Clinical Trials

Bedside Resources to Gauge Intravascular Volume Status

Start date: April 8, 2019
Phase: N/A
Study type: Interventional

The goal if this study is to employ the CardioQ-Esophageal Aortic Doppler probe to define fluid responders from non-responders among infants undergoing cranial vault reconstruction for craniosynostosis. After defining these two groups in this single arm prospective trial, the investigators will compare the predictive utility of non-invasive devices such as the CipherOx-Compensatory Reserve Index (CipherOx-CRI) and Inferior Vena Cava Collapsibility Index (IVC CI) to currently employed indices (heart rate, systolic blood pressure, urine output and pulse pressure variability) to gauge the need for additional fluid and ongoing resuscitation. If the CipherOx-CRI or IVC CI proved to be as predictive or better at predicting fluid responders, the investigators hope to replace invasive arterial lines with non-invasive tools to guide resuscitation.

NCT ID: NCT03894800 Completed - Trauma Clinical Trials

Determination of Analgesic Equipotent Doses of Inhaled Metoxyflurane vs. Intravenous Fentanyl

Start date: April 23, 2019
Phase: Phase 4
Study type: Interventional

The aim of this study is to determinate the equipotent doses of inhaled metoxyflurane vs. intravenous fentanyl.

NCT ID: NCT03764631 Completed - Clinical trials for Diabetes Mellitus, Type 2

Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration

Start date: September 26, 2018
Phase:
Study type: Observational

The objectives of this study are to assess the risk of ketoacidosis, severe urinary tract infections, volume depletion, and dehydration associated in patients with T2DM initiating Empagliflozin compared to patient initiating a dipeptidyl peptidase-4 (DPP-4) inhibitors over a 12-month period of follow-up, including the month of Ramadan

NCT ID: NCT03644654 Completed - Hypovolemia Clinical Trials

Perioperative Fluid Therapy Optimization in Spinal Surgery

Start date: August 21, 2018
Phase: N/A
Study type: Interventional

The decision to give fluids perioperatively could be based on methods used to identify preload responsiveness, either invasive or noninvasive estimates of stroke volume variation during mechanical ventilation. This study compares fluid management using continuous noninvasive cardiac output measurement with standard perioperative fluid management.